| 1 | [SID57258428] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID57258428] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID57258428] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID57258428] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504904, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504904 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 5 | [SID57258428] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504904, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504904 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 6 | [SID57258428] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 7 | [SID57258428] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 8 | [SID57258428] | Active | | | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set [AID624256, Type: screening] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Active | | BioAssay | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set | | AID | 624256 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID57258428] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 10 | [SID57258428] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 11 | [SID57258428] | Inactive | Potency | 14.1254 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | Potency | 14.1254 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID57258428] | Inactive | EC50 | 22.918 | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | EC50 | 22.918 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 588407 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 13 | [SID57258428] | Inactive | EC50 | 22.918 | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | EC50 | 22.918 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 588407 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 14 | [SID57258428] | Inactive | EC50 | 92.456 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization [AID588411, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | EC50 | 92.456 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization | | AID | 588411 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 15 | [SID57258428] | Inactive | EC50 | 92.456 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization [AID588411, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | EC50 | 92.456 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization | | AID | 588411 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 16 | [SID57258428] | Inactive | EC50 | 92.456 | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID588408, Type: confirmatory] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | EC50 | 92.456 [uM] | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 588408 | | BioAssay type | confirmatory | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 17 | [SID57258428] | Inactive | EC50 | 92.456 | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID588408, Type: confirmatory] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | EC50 | 92.456 [uM] | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 588408 | | BioAssay type | confirmatory | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 18 | [SID57258428] | Inactive | EC50 | 92.456 | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID588408, Type: confirmatory] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | EC50 | 92.456 [uM] | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 588408 | | BioAssay type | confirmatory | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 19 | [SID57258428] | Inactive | EC50 | 92.456 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | EC50 | 92.456 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 20 | [SID57258428] | Inactive | EC50 | 92.456 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | EC50 | 92.456 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 21 | [SID57258428] | Inactive | EC50 | 92.456 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | EC50 | 92.456 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 22 | [SID57258428] | Inactive | EC50 | 92.456 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | EC50 | 92.456 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 23 | [SID57258428] | Inactive | | | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity [AID588391, Type: screening] | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588391 | | BioAssay type | screening | | Target | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] | | PubMed | | | Data Table |  |
|
| 24 | [SID57258428] | Inactive | | | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity [AID588391, Type: screening] | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588391 | | BioAssay type | screening | | Target | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] | | PubMed | | | Data Table |  |
|
| 25 | [SID57258428] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) [AID492953, Type: screening] | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) | | AID | 492953 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] | | PubMed | | | Data Table |  |
|
| 26 | [SID57258428] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) [AID492972, Type: screening] | platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) | | AID | 492972 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099] | | PubMed | | | Data Table |  |
|
| 27 | [SID57258428] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) [AID492956, Type: screening] | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) | | AID | 492956 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] | | PubMed | | | Data Table |  |
|
| 28 | [SID57258428] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) [AID492956, Type: screening] | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) | | AID | 492956 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] | | PubMed | | | Data Table |  |
|
| 29 | [SID57258428] | Inactive | Potency | | A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression [AID624263, Type: confirmatory] | Parkin [Homo sapiens] [gi:3063388] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression | | AID | 624263 | | BioAssay type | confirmatory | | Target | Parkin [Homo sapiens] [gi:3063388] | | PubMed | | | Data Table |  |
|
| 30 | [SID57258428] | Inactive | Potency | | qHTS Assay to Find Inhibitors of Pin1 [AID504891, Type: confirmatory] | PIN1 gene product [Homo sapiens] [gi:5453898] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Pin1 | | AID | 504891 | | BioAssay type | confirmatory | | Target | PIN1 gene product [Homo sapiens] [gi:5453898] | | PubMed | | | Data Table |  |
|
| 31 | [SID57258428] | Inactive | Potency | | qHTS Assay to Find Inhibitors of Pin1 [AID504891, Type: confirmatory] | PIN1 gene product [Homo sapiens] [gi:5453898] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Pin1 | | AID | 504891 | | BioAssay type | confirmatory | | Target | PIN1 gene product [Homo sapiens] [gi:5453898] | | PubMed | | | Data Table |  |
|
| 32 | [SID57258428] | Inactive | Potency | | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 33 | [SID57258428] | Inactive | Potency | | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 34 | [SID57258428] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex [AID504700, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex | | AID | 504700 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] | | PubMed | | | Data Table |  |
|
| 35 | [SID57258428] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex [AID504700, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex | | AID | 504700 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] | | PubMed | | | Data Table |  |
|
| 36 | [SID57258428] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex [AID504700, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex | | AID | 504700 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] | | PubMed | | | Data Table |  |
|
| 37 | [SID57258428] | Inactive | | | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID651710, Type: screening] | RAD52 gene product [Homo sapiens] [gi:109637798] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 651710 | | BioAssay type | screening | | Target | RAD52 gene product [Homo sapiens] [gi:109637798] | | PubMed | | | Data Table |  |
|
| 38 | [SID57258428] | Inactive | Potency | | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS [AID504845, Type: confirmatory] | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS | | AID | 504845 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] | | PubMed | | | Data Table |  |
|
| 39 | [SID57258428] | Inactive | Potency | | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS [AID504845, Type: confirmatory] | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS | | AID | 504845 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] | | PubMed | | | Data Table |  |
|
| 40 | [SID57258428] | Inactive | Potency | | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS [AID504845, Type: confirmatory] | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS | | AID | 504845 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] | | PubMed | | | Data Table |  |
|
| 41 | [SID57258428] | Inactive | | | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity [AID602393, Type: screening] | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602393 | | BioAssay type | screening | | Target | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] | | PubMed | | | Data Table |  |
|
| 42 | [SID57258428] | Inactive | | | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity [AID504775, Type: screening] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity | | AID | 504775 | | BioAssay type | screening | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 43 | [SID57258428] | Inactive | | | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity [AID488896, Type: screening] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488896 | | BioAssay type | screening | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 44 | [SID57258428] | Inactive | | | uHTS fluorescent assay for identification of inhibitors of ATG4B [AID504462, Type: screening] | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | uHTS fluorescent assay for identification of inhibitors of ATG4B | | AID | 504462 | | BioAssay type | screening | | Target | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] | | PubMed | | | Data Table |  |
|
| 45 | [SID57258428] | Inactive | | | Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity [AID504441, Type: screening] | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504441 | | BioAssay type | screening | | Target | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] | | PubMed | | | Data Table |  |
|
| 46 | [SID57258428] | Inactive | | | Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity [AID504441, Type: screening] | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504441 | | BioAssay type | screening | | Target | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] | | PubMed | | | Data Table |  |
|
| 47 | [SID57258428] | Inactive | | | uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay [AID588489, Type: screening] | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay | | AID | 588489 | | BioAssay type | screening | | Target | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] | | PubMed | | | Data Table |  |
|
| 48 | [SID57258428] | Inactive | | | Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity [AID651658, Type: screening] | FGF22 gene product [Homo sapiens] [gi:10190672] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651658 | | BioAssay type | screening | | Target | FGF22 gene product [Homo sapiens] [gi:10190672] | | PubMed | | | Data Table |  |
|
| 49 | [SID57258428] | Inactive | IC50 | | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens [AID624330, Type: confirmatory] | RACGAP1 gene product [Homo sapiens] [gi:21361397] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens | | AID | 624330 | | BioAssay type | confirmatory | | Target | RACGAP1 gene product [Homo sapiens] [gi:21361397] | | PubMed | | | Data Table |  |
|
| 50 | [SID57258428] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) [AID624377, Type: screening] | ASAP1 gene product [Homo sapiens] [gi:351542238] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 57258428 | | CID | 25162458 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) | | AID | 624377 | | BioAssay type | screening | | Target | ASAP1 gene product [Homo sapiens] [gi:351542238] | | PubMed | | | Data Table |  |
|